The 'golden age' of DNA methylation in neurodegenerative diseases

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 3, 2013, Pages 523-534

  Fuso, Andrea ^a  

^a NONE

Author keywords

DNA methylation; Epigenetic assays; Epigenetics; Human disease; Neurodegeneration; One carbon metabolism

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; BETA GLUCOSIDASE; CHOLINE; CYANOCOBALAMIN; CYTOSINE; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; FOLIC ACID; FRAGILE X MENTAL RETARDATION PROTEIN; GENOMIC DNA; HOMOCYSTEINE; HUNTINGTIN; LEUCINE RICH REPEAT KINASE 2; PARKIN; PRESENILIN 1; PRESENILIN 2; PYRIDOXINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CAPILLARY ELECTROPHORESIS; CARBON METABOLISM; CENTROMERE; CEREBELLAR ATAXIA; CHROMOSOMAL INSTABILITY; COMPARATIVE GENOMIC HYBRIDIZATION; CONFERENCE PAPER; CPG ISLAND; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DNA DENATURATION; DNA METHYLATION; DNA SEQUENCE; ENVIRONMENTAL FACTOR; FALSE POSITIVE RESULT; FRONTOTEMPORAL DEMENTIA; GENE REPRESSION; GENOTYPE ENVIRONMENT INTERACTION; GROWTH RETARDATION; HIGH RESOLUTION MELTING ANALYSIS; HISTONE ACETYLATION; HUMAN; HUNTINGTON CHOREA; IMMUNE DEFICIENCY; LOSS OF FUNCTION MUTATION; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETT SYNDROME; VITAMIN DEFICIENCY;

DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENOMICS; HUMANS; IRON-BINDING PROTEINS; MUTATION; NEURODEGENERATIVE DISEASES; S-ADENOSYLMETHIONINE;

EID: 84882417694     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0618     Document Type: Conference Paper

References (96)

1. Waddington CH. The epigenotype. Endeavour 1942;1:18-20.
2. Monk M. Genomic imprinting. Genes Dev 1988;2:921-5.
3. Jaenisch R, Harbers K, Jáhner D, Stewart C, Stuhlmann H. DNA methylation, retroviruses, and embryogenesis. J Cell Biochem 1982;20:331-6.
4. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980;20:85-93.
5. Martin GR. X-chromosome inactivation in mammals. Cell 1982;29:721-4.
6. Razin A, Friedman J. DNA methylation and its possible biological roles. Prog Nucleic Acid Res Mol Biol 1981;25:33-52.
7. Jones PA, Buckley JD. The role of DNA methylation in cancer. Adv Cancer Res 1990;54:1-23.
8. Lalande M. Parental imprinting and human disease. Annu Rev Genet 1996;30:173-95.
9. Jin P, Warren ST. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 2000;9:901-8.
10. Hendrich B. Methylation moves into medicine. Curr Biol 2000;10:R60-3.
11. Kumar A. Rett and ICF syndromes: methylation moves into medicine. J Biosci 2000;25:213-4.
12. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002;21:5400-13.
13. Esteller M. Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin Immunol 2003;109:80-8.
14. El-Osta A. The rise and fall of genomic methylation in cancer. Leukemia 2004;18:233-7.
15. Sinćić N, Herceg Z. DNA methylation and cancer: ghosts and angels above the genes. Curr Opin Oncol 2011;23:69-76.
16. Kalari S, Pfeifer GP. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet 2010;70:277-308.
17. Kulis M, Esteller M. DNA methylation and cancer. Adv Genet 2010;70:27-56.
18. Ballestar E. An introduction to epigenetics. Adv Exp Med Biol 2011;711:1-11.
19. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010;28:1057-68.
20. Friso S, Choi SW. Gene-nutrient interactions in one-carbon metabolism. Curr Drug Metab 2005;6:37-46.
21. Park LK, Friso S, Choi SW. Nutritional influences on epigenetics and age-related disease. Proc Nutr Soc 2012;71:75-83.
22. Saluz H, Jost JP. Major techniques to study DNA methylation. EXS 1993;64:11-26.
23. Oakeley EJ. DNA methylation analysis: a review of current methodologies. Pharmacol Ther 1999;84:389-400.
24. Singer-Sam J, Grant M, Le Bon JM, Okuyama K, Chapman V, Monk M, et al. Use of a Hpall-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol Cell Biol 1990;10:4987-9.
25. Fuso A, Scarpa S, Grandoni F, Strom R, Lucarelli M. A reassessment of semiquantitative analytical procedures for DNA methylation: comparison of bisulfite-and Hpall polymerasechain-reaction-based methods. Anal Biochem 2006;350:24-31.
26. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-4.
27. Schatz P, Dietrich D, Schuster M. Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF. Nucleic Acids Res 2004;32:e167.
28. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007;35:e41.
29. Buller A, Pandya A, Jackson-Cook C, Bodurtha J, Tekin M, Wilkinson DS, et al. Validation of a multiplex methylationsensitive PCR assay for the diagnosis of Prader-Willi and Angelman's syndromes. Mol Diagn 2000;5:239-43.
30. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:E32.
31. Kawai J, Hirotsune S, Hirose K, Fushiki S, Watanabe S, Hayashizaki Y. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucleic Acids Res 1993;21:5604-8.
32. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 1999;59:2307-12.
33. Sadikovic B, Haines TR, Butcher DT, Rodenhiser DI. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites. Breast Cancer Res 2004;6:R329-37.
34. Shi H, Maier S, Nimmrich I, Yan PS, Caldwell CW, Olek A, et al. Oligonucleotide-based microarray for DNA methylation analysis: principles and applications. J Cell Biochem 2003;88:138-43.
35. Rauch TA, Pfeifer GP. DNA methylation profiling using the methylated-CpG island recovery assay (MIRA). Methods 2010;52:213-7.
36. Fazzari MJ, Greally JM. Introduction to epigenomics and epigenome-wide analysis. Methods Mol Biol 2010;620:243-65.
37. Fouse SD, Nagarajan RO, Costello JF. Genome-scale DNA methylation analysis. Epigenomics 2010;2:105-17.
38. Sorensen AL, Collas P. Immunoprecipitation of methylated DNA. Methods Mol Biol 2009;567:249-62.
39. Palmke N, Santacruz D, Walter J. Comprehensive analysis of DNA-methylation in mammalian tissues using MeDIP-chip. Methods 2011;53:175-84.
40. Sulewska A, Niklinska W, Kozlowski M, Minarowski L, Naumnik W, Niklinski J, et al. Detection of DNA methylation in eucaryotic cells. Folia Histochem Cytobiol 2007;45:315-24.
41. Falls JG, Pulford DJ, Wylie AA, Jirtle RL. Genomic imprinting: implications for human disease. Am J Pathol 1999;154:635-47.
42. Kwok JB. Role of epigenetics in Alzheimer's and Parkinson's disease. Epigenomics 2010;2:671-82.
43. Kanthasamy A, Jin H, Anantharam V, Sondarva G, Rangasamy V, Rana A, et al. Emerging neurotoxic mechanisms in environmental factors-induced neurodegeneration. Neurotoxicology 2012;33:833-7.
44. De Jager CA, Kovatcheva A. Summary and discussion: methodologies to assess long-term effects of nutrition on brain function. Nutr Rev 2010;68:S53-8.
45. McKay JA, Mathers JC. Diet induced epigenetic changes and their implications for health. Acta Physiol 2011;202:103-18.
46. Simmons R. Epigenetics and maternal nutrition: nature v. nurture. Proc Nutr Soc 2011;70:73-81.
47. Fuso A, Scarpa S. One-carbon metabolism and Alzheimer's disease: is it all a methylation matter? Neurobiol Aging 2011;32:1192-5.
48. Javierre BM, Hernando H, Ballestar E. Environmental triggers and epigenetic deregulation in autoimmune disease. Discov Med 2011;12:535-45.
49. Lovinsky-Desir S, Miller RL. Epigenetics, asthma, and allergic diseases: a review of the latest advancements. Curr Allergy Asthma Rep 2012;12:211-20.
50. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20.
51. Barnes PJ. Glucocorticosteroids: current and future directions. Br J Pharmacol 2011;163:29-43.
52. Herrera BM, Keildson S, Lindgren CM. Genetics and epigenetics of obesity. Maturitas 2011;69:41-9.
53. Talens RP, Boomsma DI, Tobi EW, Kremer D, Jukema JW, Willemsen G, et al. Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology. FASEBJ 2010;24:3135-44.
54. Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 2009;58:2718-25.
55. Kuroda A, Rauch TA, Todorov I, Ku HT, Al-Abdullah IH, Kandeel F, et al. Insulin gene expression is regulated by DNA methylation. PLoS ONE 2009;4:e6953.
56. Jamaluddin MD, Chen I, Yang F, Jiang X, Jan M, Liu X, et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 2007;110:3648-55.
57. Banerjee S, Bacanamwo M. DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells. Exp Cell Res 2010;316:172-80.
58. Zaina S, Lund G. Epigenetics: a tool to understand diet-related cardiovascular risk? J Nutrigenet Nutrigenomics 2011;4:261-74.
59. Lopez-Rubio JJ, Riviere L, Scherf A. Shared epigenetic mechanisms control virulence factors in protozoan parasites. Curr Opin Microbiol 2007;10:560-8.
60. Minarovits J. Microbe-induced epigenetic alterations in host cells: the coming era of patho-epigenetics of microbial infections. A review. Acta Microbiol Immunol Hung 2009;56:1-19.
61. Lill CM, Bertram L. Towards unveiling the genetics of neurodegenerative diseases. Semin Neurol 2011;31:531-41.
62. Migliore L, Coppede F. Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases. Mutat Res 2009;667:82-97.
63. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging 2011;32:1161-80.
64. Tangney CC, Aggarwal NT, Li H, Wilson RS, Decarli C, Evans DA, et al. Vitamin B12, cognition, and brain MRI measures: a crosssectional examination. Neurology 2011;77:1276-82.
65. Vogiatzoglou A, Refsum H, Johnston C, Smith SM, Bradley KM, De Jager C, et al. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 2008;71:826-32.
66. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 2006;580:2994-3005.
67. Lahiri DK, Maloney B, Zawia NH. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 2009;14:992-1003.
68. Sananbenesi F, Fischer A. The epigenetic bottleneck of neurodegenerative and psychiatric diseases. Biol Chem 2009;390:1145-53.
69. Fischer A, Sananbenesi F, Mungenast A, Tsai LH. Targeting the correct HDAC (s) to treat cognitive disorders. Trends Pharmacol Sci 2010;31:605-17.
70. Klein CJ, Botuyan MV, Wu Y, Ward CJ, Nicholson GA, Hammans S, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011;43:595-600.
71. Winkelmann J, Lin L, Schormair B, Kornum BR, Faraco J, Plazzi G, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet 2012;21:2205-10.
72. Chestnut BA, Chang Q, Price A, Lesuisse C, Wong M, Martin LJ. Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci 2011;31:16619-36.
73. Dion V, Lin Y, Hubert L Jr, Waterland RA, Wilson JH. Dnmt1 deficiency promotes CAG repeat expansion in the mouse germline. Hum Mol Genet 2008;17:1306-17.
74. Qureshi IA, Mehler MF. Epigenetic mechanisms governing the process of neurodegeneration. Mol Aspects Med 2012 Jul. 7. DOI: http://dx.doi.org/10. 10167j.mam.2012.06.011.
75. Evans-Galea MV, Carrodus N, Rowley SM, Corben LA, Tai G, Saffery R, et al. FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Ann Neurol 2012;71:487-97.
76. Laffita-Mesa JM, Bauer PO, Kourf V, Pena Serrano L, Roskams J, Almaguer Gotay D, et al. Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications. Hum Genet 2012;131:625-38.
77. Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev 2011;91:1161-218.
78. Jowaed A, Schmitt I, Kaut O, Wullner U. Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci 2010;30:6355-9.
79. Matsumoto L, Takuma H, Tamaoka A, Kurisaki H, Date H, Tsuji S, et al. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease. PLoS One 2010;5:e15522.
80. International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2). A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet 2011;7:e1002142.
81. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. Intra-individual change over time in DNA methylation with familial clustering. J Am Med Ass 2008;299:2877-83.
82. Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007;2:e895.
83. Wang SC, Oelze B, Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 2008;3:e2698.
84. Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis 2012;29:571-88.
85. Fuso A, Nicolia V, Ricceri L, Cavallaro RA, Isopi E, Mangia F, et al. S-adenosylmethionine reduces the progress of the Alzheimerlike features induced by B-vitamin deficiency in mice. Neurobiol Aging 2012;33:1482. e1-16.
86. Nicolia V, Fuso A, Cavallaro RA, Di Luzio A, Scarpa S. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A. J Alzheimers Dis 2010;19:895-907.
87. Cavallaro RA, Fuso A, Nicolia V, Scarpa S. S-adenosylmethionine prevents oxidative stress and modulates glutathione metabolism in TgCRND8 mice fed a B-vitamin deficient diet. J Alzheimers Dis 2010;20:997-1002.
88. Sung HY, Choi EN, Ahn Jo S, Oh S, Ahn JH. Amyloid proteinmediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line. Biochem Biophys Res Commun 2011;414:700-5.
89. Schrotter A, Pfeiffer K, El Magraoui F, Platta H, Erdmann R, Meyer HE, et al. The APP family members are key players in S-adenosylmethionine formation by MAT2A and modify BACE1 and PSEN1 gene expression - relevance for Alzheimer's disease. Mol Cell Proteomics 2012 Aug. 9. DOI: 10.1074/mcp. M112.019364 mcp. M112.019364.
90. Szulwach KE, Li X, Li Y, Song CX, Wu H, Dai Q, et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci 2011;14:1607-16.
91. Maloney B, Sambamurti K, Zawia N, Lahiri DK. Applying epigenetics to Alzheimer's disease via the latent early-life associated regulation (LEARn) model. Curr Alzheimer Res 2012;9:589-99.
92. Wang CS, Burke JR, Steffens DC, Hulette CM, Breitner JC, Plassman BL. Twin pairs discordant for neuro-pathologically confirmed Lewy body dementia. J Neurol Neurosurg Psychiatry 2009;80:562-5.
93. Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 2009;4:e6617.
94. Ketelaar ME, Hofstra EM, Hayden MR. What monozygotic twins discordant for phenotype illustrate about mechanisms influencing genetic forms of neurodegeneration. Clin Genet 2012;81:325-33.
95. Martin DI, Cropley JE, Suter CM. Epigenetics in disease: leader or follower? Epigenetics 2011;6:843-8.
96. Tollefsbol T, editor. Epigenetics in human disease. London, Waltham, San Diego: Elsevier, 2012:550.